Molecular cloning, sequence analysis and homology modeling of galE encoding UDP-galactose 4-epimerase of Aeromonas hydrophila.
A. hydrophila, a ubiquitous gram-negative bacterium present in aquatic environments, has been implicated in illness in humans, fish and amphibians. Lipopolysaccharides (LPS), a surface component of the outer membrane, are one of the main virulent factors of gram-negative bacteria. UDP-galactose 4-epimerase (GalE) catalyses the last step in the Leloir pathway of galactose metabolism and provides precursor for the biosynthesis of extracellular LPS and capsule. Due to its key role in LPS biosynthesis, it is a potential drug target. The present study describes cloning, sequence analysis and prediction of three dimensional structure of the deduced amino acid sequence of the galE of A. hydrophila AH17. The cloned galE consists of the putative promoter-operator region, and an open reading frame of 338 amino acid residues. Sequence alignment and predicted 3Dstructure revealed that the GalE of A. hydrophila consists of the signature sequences of the epimerase super family. The present study reports the molecular modeling / 3D-structure prediction of GalE of A. hydrophila. Further, the potential regions of the enzyme that can be targeted for drug design are identified.
Agarwal
Shivani
S
Gene Regulation Laboratory, School of Biotechnology, Jawaharlal Nehru University, New Delhi - 110067, India.
Gopal
Keshav
K
Chhabra
Gagan
G
Dixit
Aparna
A
Infect Immun. 1996 Mar;64(3):855-60
8641792
J Infect Dis. 1975 May;131(5):553-8
1092768
Infect Immun. 2001 Jan;69(1):435-45
11119535
J Mol Graph. 1990 Mar;8(1):52-6, 29
2268628
Clin Infect Dis. 1998 Aug;27(2):332-44
9709884
J Bacteriol. 1996 Oct;178(20):5916-24
8830687
Can J Vet Res. 1986 Apr;50(2):165-73
3530414
Biochemistry. 1997 Sep 2;36(35):10675-84
9271498
Infect Immun. 2000 May;68(5):2594-601
10768949
Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
7984417
Clin Microbiol Rev. 1991 Oct;4(4):397-410
1747858
Methods Enzymol. 1997;277:396-404
9379925
Adv Protein Chem. 1968;23:283-438
4882249
J Bacteriol. 2007 Jan;189(2):540-50
17098903
Curr Microbiol. 1998 Aug;37(2):144-8
9662617
Infect Immun. 2006 Jan;74(1):537-48
16369010
Nucleic Acids Res. 2003 Jul 1;31(13):3381-5
12824332
Microb Pathog. 1996 Jun;20(6):325-33
8831828
Biochemistry. 2000 May 16;39(19):5691-701
10801319
J Bacteriol. 1990 Aug;172(8):4392-8
2198256
J Biol Chem. 2003 Nov 7;278(45):43885-8
12923184
Infect Immun. 2002 May;70(5):2326-35
11953367
DNA Seq. 2007 Aug;18(4):302-6
17541836
J Biol Chem. 2001 May 4;276(18):15131-6
11279032